The evolution of adjunctive antiplatelet therapy in non urgent PCI

EBAC Accredited Educational Programme - Programme supported by an unrestricted educational grant from ASTRAZENECA

Chairpersons: H. Katus, P.W. Serruys


Learning Objectives

  • To learn about evolving evidence in adjunctive antiplatelet therapy
  • To appreciate the importance of discharge treatment plans
  • To understand the issues surrounding short versus long-term antiplatelet therapy

Presentations available when logged in:

  • Introduction and objectives
  • Early studies of clopidogrel in ACS and coronary artery disease
  • Evidence for the use of newer antiplatelet agents in non-urgent PCI
  • Antiplatelet treatment beyond the cathlab
  • Future directions for antiplatelet agents in stable coronary artery disease and ACS
  • Take-home message